View Older Stories View More Recent Stories
-
Mylan (MYL) PT Lowered to $50 at Citi
-
Omega's 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More...)
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
Omega Advisors 13F Shows New Stake in Humana (HUM), Wells Fargo (WFC), Gold ETF (GLD), Sells AET (AET) (More...)
-
Mylan (MYL) PT Raised to $58 at Citi, Added To Citi US Focus List, Top Pick for 2018
-
Pre-Open Movers 08/16: (URBN) (TGT) (A) (PSTI) (MYL (BMY)
-
UPDATE: Citi Upgrades Mylan (MYL) to Buy
-
Wall Street hits new highs as banks soar on rate hike hopes
-
Wall Street hits new highs as banks soar on rate hike hopes
-
Wall Street hits new highs as banks soar on rate hike hopes
-
Tepper's Appaloosa Enters American Airlines (AAL), Micron (MU), JC Penney (JCP), Pfizer (PFE) (more...) - 13F
-
Pre-Open Movers 01/31: (DRYS) (MNTA) (SANM) Higher; (UAA) (RRTS) (TEVA) Lower (more...)
-
Citi Downgrades Mylan (MYL) to Neutral
-
Complete Donald Trump Stock Impact Guide
-
Glenview Capital Enters Kindred Health (KND), Sirius XM (SIRI) (more...)
-
Eton Park Enters CIGNA (CI), Sherwin-Williams (SHW), Raises Adobe (ADBE) (more...)
-
Robbins' Glenview Capital 13F Shows New Stakes in Bank of New York (BK), Comcast (CMCSA), Hubbell (HUB-B), Sells Fox (FOXA)
-
Eton Park Enters Adobe (ADBE), Catamaran (CRTX), Raises Microsoft (MSFT) Sharply
-
StreetInsider Top 50 Takeover Targets Notable Changes: (MSO) (MYL) (CSC)
-
Teva (TEVA) Bid For Mylan (MYL) Likely Imminent - Bloomberg Citing Citi
-
UPDATE: Teva Pharma (TEVA) Said to Seek $25B in Financing for Mylan (MYL) Takeover
-
Notable Mergers and Acquisitions 4/21: (MYL)/(TEVA) (ECHO) (VNR)/(LRE) (BBRY)
-
Top 10 News for 4/13 - 4/17: China Regulation, Greek Debt Rattle Markets; Netflix Rockets on Results; M&A News, Rumors Abound
-
Citi Downgrades Mylan (MYL) to Neutral
-
Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results
-
Pre-Open Stock Movers 07/14: (PGNX) (KNDI) (URS) Higher; (HLIT) (RVBD) (GTAT) Lower (more...)
-
Citi Upgrades Mylan (MYL) to Buy
-
Paulson & Co Enters American Airlines (AAL), Extended Stay America (STAY), GM (GM) (more...)
-
Citi Starts Mylan (MYL) at Neutral
-
Notable Analyst Rating Changes 05/10: (FST) (EIX) (BSX) Upgraded; (MDR) (DNDN) (LTD) Downgraded
-
Mylan (MYL) is No Generic When it Comes to Growth Potential - Barron's
-
Paulson & Co. Trims Some Gold (GLD) and Exits Banks in a Big Way (BAC) (C) (WFC)
-
Notable Analyst Rating Changes 02/14: (CVE) (WSM) (MYL) Upgraded; (BAC) (YGE) (STI) Downgraded
-
Barclays 2012 Top Picks: Becoming Somewhat More Optimistic - Signs of Progress, Growth and Soft Landings
-
Paulson's Paulson & Co. Releases Q3 2011 13F
-
Notable Analyst Rating Changes 11/07: (HD) (TOL) (UDR) Upgraded; (ALU) (VRTX) (SD) Downgraded
-
Notable Analyst Rating Changes 09/28: (BMRN) (LEAP) (MAS) Upgraded; (BZ) (BPO) (KMB) Downgraded
-
Notable Analyst Rating Changes 09/22: (NFLX) (INTC) (YHOO) Upgraded; (JNJ) (ZMH) (PG) Downgraded
-
Paulson & Co. Slashes Stake in BofA (BAC), Citigroup (C); Shows New Stakes in Mosaic (MOS) and News Corp (NWSA)
-
Paulson's Paulson & Co Shows New Stakes In Alpha Natural (ANR), Family Dollar (FDO), HP (HP); Raises Transocean (RIG) and Liquidates Pfizer (PFE)
-
Notable Analyst Rating Changes 05/04: (FSLR) (SNY) (FE) Upgraded; (MEE) (NSC) (MYL) Downgraded
-
Paulson's Paulson & Co. Reduces Citi (C) Exposure; Keeps Gold Level; Likes Tech (STX)(RIG)ABX)(JPM)
-
Notable 52-Week Highs and Lows of the Day 01/18: ARIA, VOD, MYL, SSN High; EAR, AB Low
-
Notable Analyst Rating Changes 12/14: ABC, CMCSA, COV, AMGN Upgraded; MFN, TSO, VECO, CAKE Downgraded
-
Paulson's Paulson & Co. Keeps Gold Rush Alive, Moves Out of Goldman and Increases Citi Stake (C, GS, ABX, APC, XOM, More...)
-
Notable Analyst Rating Changes 09/23: EW, MYL, NVDA, ENDP Upgraded; DYN, MO, OXPS, CVVT Downgraded
-
John Paulson Shows New Stakes In Exxon Mobil (XOM) and Goldman Sachs (GS), Raises Pfizer (PFE) Stake
-
Citi on Generic Pharmaceuticals: Multiple Compression Overdone
-
Citi Maintains a 'Buy' on Mylan (MYL); Lowering 2Q10 EPS, But Maintaining 2010 Outlook
-
Citi Reiterates a 'Buy' on WPI, TEVA & MYL After Generic Approval of VALTREX

